Standard of Care: Medical and Surgical Treatments
At a Glance
Standard care for achondroplasia includes pharmacological treatments like the daily injection vosoritide, which blocks growth-inhibiting signals in bones. Surgical interventions are also common to manage complications, including foramen magnum decompression and procedures to correct bowed legs.
Treatment for achondroplasia has entered a new era. Historically, medical care focused almost entirely on managing complications through surgery. Today, standard of care includes both pharmacological (medication-based) and surgical options, working together to improve long-term health and quality of life [1][2].
Pharmacological Treatment: Targeting the Source
The most significant change in care is the approval of vosoritide, a medication that targets the biology of achondroplasia directly [3].
- How it Works: As discussed in earlier pages, the FGFR3 gene sends too many “stop” signals to the bones. Vosoritide is a synthetic version of a natural protein (C-type natriuretic peptide) that binds to a different receptor to block those “stop” signals [3][4].
- Beyond Height: While vosoritide is often discussed in terms of height, research suggests it may also improve the shape of the spine, reduce the risk of spinal stenosis, and potentially improve the size of the foramen magnum [5][6].
- Administration and Side Effects: Vosoritide requires a daily subcutaneous (under the skin) injection, meaning parents must be comfortable administering it at home. Common side effects to monitor include injection site reactions and transient drops in blood pressure [3][7].
- Eligibility: It is currently used in children whose epiphyses (growth plates) are still “open” [8]. The decision to start is a highly personal, collaborative one between the family and their medical team [9].
Neurosurgical Interventions: Protecting the Spinal Cord
The most common surgeries in infancy and early childhood involve the brain and spine [10].
- Foramen Magnum Decompression (FMD): This is the surgical widening of the opening at the base of the skull.
- When it’s necessary: Surgery is indicated if an MRI shows significant cervicomedullary compression or if a sleep study shows a high Central Apnea Index [11][12].
- Observation: If an infant has narrowing but no clinical symptoms (like breathing issues or weakness), many specialists prefer “watchful waiting” with frequent monitoring [13][14].
- Hydrocephalus Management: If fluid builds up in the brain, surgeons may use a VP shunt (a tube that drains fluid) or an Endoscopic Third Ventriculostomy (ETV), which creates a natural drainage path within the brain [15][16].
ENT and Orthopedic Management: Breathing and Walking
As children grow, other surgical needs may arise to support their daily function [1].
- Adenotonsillectomy: If a child has obstructive sleep apnea (snoring or gasping caused by a physical blockage), removing the tonsils and adenoids is often the first and most effective treatment [17][18].
- Genu Varum (Bowed Legs):
- Guided Growth (Hemiepiphysiodesis): This is a less invasive surgery where small plates are used to “guide” the growth of the bone as the child grows, gradually straightening the leg [19].
- Osteotomy: In more severe cases, or once growth is complete, a surgeon may need to cut and reposition the bone (osteotomy) to correct the alignment [20].
Essential Safety Note: Anesthesia Precautions
If surgery is required, it is critical to know that individuals with achondroplasia face unique anesthesia risks [21]. Due to craniofacial differences, emergency intubations can be difficult, and their airways require careful management by an experienced pediatric anesthesiologist. Furthermore, spinal narrowing (stenosis) makes standard spinal blocks and epidurals highly complex or dangerous. Any surgical team you work with must be explicitly familiar with the anesthesia protocols for skeletal dysplasia.
Surgery in achondroplasia is rarely a “rush” unless there is a critical safety issue, such as severe cord compression [22]. Most centers follow a “Function over Appearance” rule: surgery is recommended when a condition interferes with breathing, walking, or neurological safety [1][23]. Regular surveillance is the key to knowing exactly when to move from observation to intervention.
Common questions in this guide
How does vosoritide work for achondroplasia?
When does a child with achondroplasia need foramen magnum decompression surgery?
What are the surgical options for bowed legs in achondroplasia?
Why are anesthesia risks higher for individuals with achondroplasia?
How is sleep apnea treated in children with achondroplasia?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my child a candidate for vosoritide, and are their growth plates currently open enough to benefit?
- 2.What specific clinical signs (like myelopathy or apnea indices) would move us from 'observation' to 'surgery' for the foramen magnum?
- 3.For lower limb bowing, is my child a candidate for 'guided growth' (hemiepiphysiodesis) rather than a full osteotomy?
- 4.How will we monitor for potential side effects, like low blood pressure, if we start vosoritide?
- 5.Does our ENT and anesthesiologist have experience with the unique airway anatomy of children with achondroplasia?
- 6.If my child has hydrocephalus, would they be a better candidate for an ETV (endoscopic third ventriculostomy) or a traditional shunt?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (23)
- 1
International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia.
Savarirayan R, Hoover-Fong J, Ozono K, et al.
Nature reviews. Endocrinology 2025; (21(5)):314-324 doi:10.1038/s41574-024-01074-9.
PMID: 39757323 - 2
Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide.
Hoskens H, Aponte JD, Da Silva C, et al.
Genetics in medicine open 2025; (3()):103463 doi:10.1016/j.gimo.2025.103463.
PMID: 41340868 - 3
Vosoritide: First Approval.
Duggan S
Drugs 2021; (81(17)):2057-2062 doi:10.1007/s40265-021-01623-w.
PMID: 34694597 - 4
Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature.
Hisado-Oliva A, Ruzafa-Martin A, Sentchordi L, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(1)):91-97 doi:10.1038/gim.2017.66.
PMID: 28661490 - 5
Effect of vosoritide on spine morphology in children with achondroplasia: 1-year results from a randomized phase 2 study.
Irving M, Savarirayan R, Hoover-Fong JE, et al.
Journal of the Endocrine Society 2026; (10(3)):bvag008 doi:10.1210/jendso/bvag008.
PMID: 41783511 - 6
Changes in the Alignment of the Spine and Lower Limb in Children With Achondroplasia Treated With Vosoritide: A Single-center, 1-year Follow-up Prospective Study.
Sawamura K, Kitoh H, Kamiya Y, et al.
Journal of pediatric orthopedics 2025; (45(8)):519-524 doi:10.1097/BPO.0000000000002980.
PMID: 40231376 - 7
Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life.
Savarirayan R, Irving M, Wilcox WR, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2024; (26(12)):101274 doi:10.1016/j.gim.2024.101274.
PMID: 39305160 - 8
New Drug Treats Pediatric Achondroplasia.
Aschenbrenner DS
The American journal of nursing 2022; (122(3)):18 doi:10.1097/01.NAJ.0000822964.26069.7e.
PMID: 35200181 - 9
Efficacy of vosoritide in the treatment of achondroplasia.
Paton DM
Drugs of today (Barcelona, Spain : 1998) 2022; (58(9)):451-456 doi:10.1358/dot.2022.58.9.3422313.
PMID: 36102905 - 10
Recommendations for neuroradiological examinations in children living with achondroplasia: a European Society of Pediatric Radiology and European Society of Neuroradiology opinion paper.
Wright J, Cheung M, Siddiqui A, et al.
Pediatric radiology 2023; (53(12)):2323-2344 doi:10.1007/s00247-023-05728-0.
PMID: 37674051 - 11
Centrally mediated obstructive apnoea and restenosis of the foramen magnum in an infant with achondroplasia.
Cocca A, Thompson D, Rahim Z, et al.
British journal of neurosurgery 2023; (37(3)):409-412 doi:10.1080/02688697.2020.1817315.
PMID: 32924616 - 12
Sleep-Disordered Breathing in an Infant With Achondroplasia and Foramen Magnum Stenosis.
Feller C, Senthilvel E
Cureus 2024; (16(3)):e56291 doi:10.7759/cureus.56291.
PMID: 38623108 - 13
Management and outcomes of foramen magnum stenosis in children with achondroplasia at a single center over 15 years.
Sandvik U, Ringvall E, Klangemo K, et al.
Journal of neurosurgery. Pediatrics 2024; (34(5)):470-478 doi:10.3171/2024.6.PEDS23586.
PMID: 39213664 - 14
Polysomnography as an indicator for cervicomedullary decompression to treat foramen magnum stenosis in achondroplasia.
Sano M, Takahashi N, Nagasaki K, et al.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2018; (34(11)):2275-2281 doi:10.1007/s00381-018-3880-0.
PMID: 29959505 - 15
Challenges in endoscopic third ventriculostomy for patients with achondroplasia: a focus on third ventricle floor anatomy.
Shin JY, Kim AH, Ko JM, et al.
Journal of neurosurgery. Pediatrics 2024; (34(5)):462-469 doi:10.3171/2024.6.PEDS2472.
PMID: 39213660 - 16
Hydrocephalus in achondroplasia: efficacy of endoscopic third ventriculostomy.
Kim J, Patel VJ, El Ahmadieh TY, et al.
Journal of neurosurgery. Pediatrics 2022; (29(3)):268-275 doi:10.3171/2021.9.PEDS21242.
PMID: 34920430 - 17
Achondroplasia and obstructive sleep apnea: surgical outcomes and comparison to general population.
Ascencio CG, Wani A, Mitchell RB
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2025; (21(5)):883-890 doi:10.5664/jcsm.11574.
PMID: 39912226 - 18
Characteristics of sleep disordered breathing in children with achondroplasia.
Feller C, Gunaratnam B, El-Kersh K, Senthilvel E
Sleep & breathing = Schlaf & Atmung 2025; (29(1)):100 doi:10.1007/s11325-025-03258-7.
PMID: 39934423 - 19
Hemiepiphysiodesis for Lower Extremity Coronal Plane Angular Correction in the Distal Femur and Proximal Tibia in Children With Achondroplasia.
Makarewich CA, Zhang E, Stevens PM
Journal of pediatric orthopedics 2023; (43(8)):e639-e642 doi:10.1097/BPO.0000000000002442.
PMID: 37253708 - 20
Correction of Bowleg Deformity in Achondroplasia through Combined Bony Realignment and Lateral Collateral Ligament Tightening.
Kurian BT, Belthur MV, Jones S, et al.
Strategies in trauma and limb reconstruction 2019; (14(3)):132-138 doi:10.5005/jp-journals-10080-1441.
PMID: 32742428 - 21
Editorial: Neonatal management of achondroplasia: one hospital's geosocial approach to improve patient outcomes.
Gooch C, Robin NH, Hurst ACE
Current opinion in pediatrics 2019; (31(6)):691-693 doi:10.1097/MOP.0000000000000814.
PMID: 31693574 - 22
Cranio-cervical junction malformation causing cord compression in infant with achondroplasia: a bigger picture.
Caratella S, Tarazi M, Tomalieh FT, et al.
British journal of neurosurgery 2023; (37(4)):886-888 doi:10.1080/02688697.2019.1698009.
PMID: 31790284 - 23
New treatments for children with achondroplasia.
Savarirayan R, Hoover-Fong J, Yap P, Fredwall SO
The Lancet. Child & adolescent health 2024; (8(4)):301-310 doi:10.1016/S2352-4642(23)00310-3.
PMID: 38485412
This page provides educational information about achondroplasia treatments and surgeries. Always consult your child's pediatrician, neurosurgeon, or geneticist for specific medical advice.
Get notified when new evidence is published on Achondroplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.